Vipera kaznakovi

Venom composition image
Figure 1: Compositions of Vipera kaznakovi, studied at the proteomic level from (A) Russia (Kovalchuk et al., 2016); quantified by the whole venom in-solution shotgun approach (MaxLFQ) and (B) Turkey (Petras et al., 2019); quantified by the snake venomics approach (C18-RP-HPLC 214nm + 1D SDS PAGE densiometry)

The venoms contain the following families:
PLA2 (phospholipase A2), svMP (metalloproteinase), CTL/Snaclec (C-type lectin related protein), svSP (serine protease), Cysteine-rich secretory proteins (CRISP), LAAO (L-amino acid oxidase), VEGF and DI (disintegrin).
Additionally, as "other" labeled families: NGF, 5NUC (5'-nucleotidase), PDE (phosphodiesterase), HYAL (hyaluronidase), PLB (phospholipase B), glutathione (GSH) peroxidase, amino Peptidase and further proteins;
as well as peptides like svMP-i (tripeptic svMP inhibitors of pHpG), NP (natriuretic peptide) and other peptides.
Clinical Effects, Treatment, Antivenoms See the WHO venomous snake database to access snake distribution and antivenom products.